Resources for News Media
The NCI press office is the central news contact for all members of the media. The office can assist you in arranging interviews with NCI researchers and in providing accurate and timely cancer research news and information.
For information about NCI's history and current activities, see NCI Overview and Budget and Appropriations.
Connect with Us
Our office hours are Monday through Friday, 9 a.m. to 5 p.m. ET.
Email: ncipressofficers@mail.nih.gov
Phone: 240-760-6600
Social Media:
@NCIMedia
NCI's YouTube Channel
Address:
Building 31, Room 10A25
31 Center Drive MSC 2580
Bethesda, MD 20892-2580
Recent Interviews from Scientists at NCI
-
The Cancer Grand Challenges Program Awards $100 Million To Four Research Teams
June 16, 2022 | Forbes
The National Cancer Institute (NCI), part of the National Institutes of Health, announced on Thursday that four international research teams had been selected to receive a total of $100 million as part of the Cancer Grand Challenges program. Each team will receive $25 million over five years as it tackles one of cancer’s most challenging problems. -
Screening and Early Treatment Reduce Anal Cancer in People With HIV
June 17, 2022 | POZ
Screening people with HIV for precancerous anal cell changes and treating them promptly lowered the risk of progression to anal cancer by more than half, according to results from the ANCHOR study published this week in the New England Journal of Medicine. -
'We still are dying at alarming rates': Black cancer death rates are falling but remain higher than others, study finds
May 19, 2022 | USA Today
Despite declining cancer death rates, Black people still died of cancer at higher rates than any other racial group, a new study shows. -
Study uncovers clues to rise in uterine cancer death rates
May 5, 2022 | AP News
A rare but aggressive kind of uterine cancer appears to be driving an increase in U.S. deaths from the disease, particularly among Black women, researchers reported Thursday. -
NCI-COG Pediatric MATCH study shows benefit of genetic screening in refractory tumors
April 4, 2022 | Baylor College of Medicine
Cancer therapies targeting specific genetic mutations may offer benefits to patients for whom other standard chemotherapy treatments have not effectively treated their tumor. However, genetic screening of tumors is not routinely performed for pediatric and young adult cancer patients. To increase access to tumor genetic screening and study the utility of this strategy, the National Cancer Institute (NCI), part of the National Institutes of Health, and the Children’s Oncology Group (COG) partnered to create the NCI-COG Pediatric MATCH trial -
NCI program to provide molecular characterization of childhood cancers
March 21, 2022 | Healio
Dr. Brigitte Widemann talks about the Molecular Characterization Initiative. -
Global Health and the National Cancer Institute
January 27, 2022 | That Medic Podcast
In this episode, we spoke to Dr. Satish Gopal, Director of the Center for Global Health at the National Cancer Institute. We discussed why students should care about global health, his experience as the only certified medical oncologist in Malawi, a country of 18 million, and how he is helping bridge disparities in the global cancer burden.
Trending Topics
-
Cancer Treatment Vaccines
Cancer treatment vaccines treat cancer by strengthening the body’s natural defenses against the cancer. This page covers how cancer treatment vaccines work against cancer, cancers that are treated with them, and the side effects they may cause.
-
Childhood Cancer Research Results and Study Updates
Find research articles on childhood cancer, which may include news stories, clinical trials, blog posts, and descriptions of active studies.
-
Cancer death rates among Black people declined over time, but remain higher than other racial and ethnic groups
From 1999—2019, US rates of cancer death fell among Black people. Yet, in 2019, their rates remained higher than those of other racial and ethnic groups.
-
Uterine Cancer—Patient Version
Uterine cancers can be of two types: endometrial cancer (common) and uterine sarcoma (rare). Endometrial cancer can often be cured. Uterine sarcoma is often more aggressive and harder to treat. Start here to find information on uterine cancer treatment, causes and prevention, screening, research, and statistics.
-
NCI COVID-19 in Cancer Patients Study (NCCAPS)
The NCI COVID-19 in Cancer Patients Study, or NCCAPS, is a natural history study of COVID-19 in people with cancer. The knowledge gained from this study will help doctors better manage treatment for people with cancer and COVID-19 in the future.
-
Immunotherapy to Treat Cancer
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. This page covers the types of immunotherapy, how it is used against cancer, and what you can expect during treatment.
-
Cancer Cabinet Community Conversations: Doubling Clinical Trials Accrual
The National Cancer Institute hosted a virtual roundtable titled “Cancer Cabinet Community Conversations: Doubling Clinical Trials Accrual” as part of a series of coordinated Cancer Cabinet Community Conversations on May 4, 2022, as part of the Cancer Moonshot Initiative. This is a recording on YouTube.
Multimedia from NCI
50 Years of Cancer Treatment and Diagnostics
Clinical trials, innovation in research, and technology have improved cancer treatment and diagnostics in public health. Listen to Healthcast’s National Cancer Act podcast series to learn more.
Recent News Releases
-
NCI awards $23 million to establish centers of excellence to study telehealth for cancer care
NCI awards $23 million to academic institutions to establish centers of excellence to conduct research on the role of telehealth in delivering cancer care.
-
Interferon treatment may reduce severity of COVID-19 in people with certain genetic factors
In patients with certain variations in the OAS1 gene, treatment for severe COVID-19 with interferons, a type of protein that can help the body’s immune system fight infections, decreased the viral load of SARS-CoV-2, a new study found.
-
COVID-19 was third leading cause of death in the United States in both 2020 and 2021
COVID-19 was the third leading cause of death in the United States between March 2020 and October 2021, according to an analysis of national death certificate data by researchers at the National Cancer Institute.